Results 241 to 250 of about 12,937,092 (315)
Issues in accessing and sharing confidential survey and social science data [PDF]
, 2003 Virginia A. de Wolf
openalex +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source
The Emerging Clinical Relevance of Artificial Intelligence, Data Science, and Wearable Devices in Headache: A Narrative Review. [PDF]
Life (Basel)Danelakis A +3 more
europepmc +1 more source
Molecular Oncology, EarlyView.Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source
A Brief Reflection on Judicial Use of Social Science Data [PDF]
, 1983 Higginbotham, Patrick E.
core +1 more source
Data science and distributed intelligence: recent developments and future insights [PDF]
, 2012 Cuzzocrea, A., Gaber, M.
core
India Policy Insights: A geospatial and temporal data science and visualization platform and architecture. [PDF]
SoftwareXJain D +5 more
europepmc +1 more source
Molecular Oncology, EarlyView.A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul +11 more
wiley +1 more source